You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 92 No. 4, October 1965 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Porphyria Cutanea Tarda

Association With Abnormal Iron Metabolism

JOHN H. EPSTEIN, MD; JAMES B. PINSKI, MD

Arch Dermatol. 1965;92(4):362-366.


Abstract

High serum iron values with marked transferrin saturation were noted in four of 15 patients with porphyria cutanea tarda (PCT). Four others had serum iron and saturation levels near the upper limits of normal. In addition, the presence of hepatic dysfunction and the increased incidence of diabetes in this disease were confirmed. However, a relationship between the characteristic chemical and photocutaneous features of PCT and hemochromatosis could not be substantiated.

The mechanisms responsible for the elevated iron values were discussed. The available evidence to date suggests increased absorption rather than reduced utilization as the cause of the abnormal iron findings in PCT.

An unexplained but significant tendency to polycythemia was also noted in our series. Two patients had hemoglobin levels greater than 17.5 gm/100cc and six others had values greater than 16 gm/100cc and packed cell volumes higher than 50%, or both.



Author Affiliations

SAN FRANCISCO, CALIF

From the Division of Dermatology, Department of Medicine, University of California School of Medicine (Dr. Epstein), and Letterman General Hospital, Dermatology Service, Presidio of San Francisco.


Footnotes

Accepted for publication July 6, 1965.

Reprint requests to Division of Dermatology, Department of Medicine, University of California, San Francisco 94122 (Dr. Epstein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Porphyria Cutanea Tarda in a Patient With Agnogenic Myeloid Metaplasia
Fivenson and King
Arch Dermatol 1984;120:538-539.
ABSTRACT  

Porphyria Cutanea Tarda Associated With Disinfectant Misuse
Lynch et al.
Arch Intern Med 1975;135:549-552.
ABSTRACT  

Porphyria Cutanea Tarda Associated With Lymphosarcoma
Rayhanzadeh et al.
Arch Dermatol 1975;111:129-129.
ABSTRACT  

Porphyria Cutanea Tarda: Report of a Case Treated With Phlebotomies and Supplemental Iron
Wechsler
Arch Dermatol 1972;105:432-433.
ABSTRACT  

Estrogen-Induced Porphyria Cutanea Tarda: Report of Three Cases
Roenigk and Gottlob
Arch Dermatol 1970;102:260-266.
ABSTRACT  

Phlebotomy Therapy in Cutaneous Porphyria: Effect on Iron and Trace Metals
Walsh et al.
Arch Dermatol 1970;101:167-172.
ABSTRACT  

Iron Overload in Cutaneous Porphyria
Sauer and Funk
Arch Intern Med 1969;124:190-196.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.